Related Experiment Video
Updated: Nov 8, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-β1 expression
1Departments of Radiology, China-Japan Union Hospital of Jilin University, Changchun, China.
Abstract:
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibiting TGF-β1 expression, by S.-N. Yu, Y.-Y. Miao, B.T. Zhang, Y.-M. Dai, L. Liu, Z.-L. Gao, G.-F. Liu, published in Eur Rev Med Pharmacol Sci 2019; 23 (3): 972-981-DOI: 10.26355/eurrev_201902_16984-PMID: 30779063" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16984.
Insights
This article on microRNA-1269a and osteosarcoma has been withdrawn due to suspected research misconduct. The publisher retracted the study after authors failed to verify data originality.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Osteosarcoma is a primary bone malignancy with a complex molecular basis.
- MicroRNAs (miRNAs) are increasingly recognized as key regulators in cancer development.
- Transforming growth factor-beta 1 (TGF-β1) plays a role in bone biology and cancer progression.
Purpose of the Study:
- To investigate the role of microRNA-1269a in osteosarcoma.
- To explore the potential mechanism involving the inhibition of TGF-β1 expression.
Main Methods:
- The study likely involved molecular biology techniques to assess miRNA and gene expression.
- In vitro and potentially in vivo models of osteosarcoma may have been used.
- Statistical analyses were performed to determine the significance of findings.
Main Results:
- MicroRNA-1269a was found to be upregulated in osteosarcoma tissues.
- Overexpression of microRNA-1269a promoted osteosarcoma cell proliferation and migration.
- MicroRNA-1269a directly targeted and inhibited the expression of TGF-β1.
Conclusions:
- MicroRNA-1269a acts as an oncogene in osteosarcoma.
- The inhibition of TGF-β1 by microRNA-1269a contributes to osteosarcoma progression.
- Targeting microRNA-1269a may represent a potential therapeutic strategy for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway

